Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Ginkgo Bioworks Partners with Eli Lilly for AI Drug Discovery to Boost Business Opportunities.
Oct 05, 2026
Contract Type
partnership
BostonOtherManufacturingBiotechnologySustainabilitySoftwareScience And Engineering
Description
Ginkgo Bioworks announced a partnership with Eli Lilly last month to focus on AI-driven drug discovery. This collaboration has resulted in a significant increase in Ginkgo's stock value, which has doubled since the announcement.
Company Information
Company
Ginkgo Bioworks
Location
Boston, Massachusetts, United States
About
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.